Issue Type: Unraveling Payment Concepts

  • DPL, Commonwealth Fund and Health Affairs Release Policy Papers

  • CMS Changes Payment Policy for Drugs Purchased Through 340B

  • DPL Responds to CMS Proposed Changes to OPPS Policy

  • A $475,000 price tag for a new cancer drug: crazy or meh?

  • DPL and Collaborators to Publish Drug Pricing Primer Series

  • Is Outcomes-Based Contracting Worth It?

  • Bill to Kill CMS Drug Demo Gets Congressional Hearing

  • A Q&A with Peter Bach

  • Dr Steve Miller Highlights the Importance of Working Closely With Oncologists

  • Exclusive: Makers Took Big Price Increases on Widely Used U.S. drugs